Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT)

DEVICE2 trials

Sponsors

Central Hospital, Nancy, France, University of Wisconsin, Madison

Conditions

DosimetryNeuroendocrine TumorsSomatostatin Receptor-positive Neuroendocrine Tumor

Phase 1

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

RecruitingNCT06122610

University of Wisconsin, MadisonNeuroendocrine Tumors, Somatostatin Receptor-positive Neuroendocrine Tumor

Start: 2025-03-07End: 2026-06-01Target: 10Updated: 2026-03-19

Unknown Phase

Dosimetry Using a CZT-camera Following LUTATHERA® Therapy

CompletedNCT04467567

Central Hospital, Nancy, FranceDosimetry

Start: 2020-11-27End: 2023-07-24Updated: 2024-02-09